Association of ABCG1 gene methylation and its dynamic change status with incident type 2 diabetes mellitus: the Rural Chinese Cohort Study
- PMID: 32968204
- DOI: 10.1038/s10038-020-00848-z
Association of ABCG1 gene methylation and its dynamic change status with incident type 2 diabetes mellitus: the Rural Chinese Cohort Study
Abstract
To explore whether DNA methylation of the ATP-binding cassette G1 (ABCG1) gene and its dynamic change are associated with incident type 2 diabetes mellitus (T2DM). We conducted a nested case-control study with 286 pairs of T2DM cases and matched controls nested in the Rural Chinese Cohort Study. Conditional logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for incident T2DM risk according to ABCG1 methylation level at baseline and its dynamic change at follow-up examination. Spearman's rank correlation coefficients were used to analyze the association between ABCG1 methylation and its possible risk factors in the control group. We found that T2DM risk increased by 16% (OR = 1.16, 95% CI = 1.02-1.31) with each 1% increase in DNA methylation levels of the ABCG1 loci CpG13 and CpG14. DNA methylation change of the ABCG1 locus CpG15 during the 6-year follow-up was associated with increased T2DM risk: T2DM risk increased by 78% in the upper tertile group (methylation gain ≥5%) versus lower tertile group (methylation gain <1%) (OR = 1.78, 95% CI = 1.01-3.15). Furthermore, body mass index was positively correlated with the DNA methylation level of the ABCG1 loci CpG13, CpG14 and CpG15. In conclusion, DNA methylation levels of the ABCG1 loci CpG13 and CpG14 and the methylation gain of locus CpG15 were positively associated with incident T2DM risk, which may suggest a possible etiologic pattern for T2DM and potentially improve T2DM prediction in rural Chinese people.
Similar articles
-
DNA methylation and type 2 diabetes: a systematic review.Clin Epigenetics. 2024 May 16;16(1):67. doi: 10.1186/s13148-024-01670-6. Clin Epigenetics. 2024. PMID: 38755631 Free PMC article.
-
Association Between ABCG1/TCF7L2 and Type 2 Diabetes Mellitus: An Intervention Trial Based on a Case-Control Study.J Diabetes Res. 2025 Feb 26;2025:9356676. doi: 10.1155/jdr/9356676. eCollection 2025. J Diabetes Res. 2025. PMID: 40225014 Free PMC article.
-
Association of TCF7L2 gene polymorphisms, methylation, and gene-environment interaction with type 2 diabetes mellitus risk: A nested case-control study in the Rural Chinese Cohort Study.J Diabetes Complications. 2021 Mar;35(3):107829. doi: 10.1016/j.jdiacomp.2020.107829. Epub 2020 Dec 31. J Diabetes Complications. 2021. PMID: 33419631
-
Association of methylation risk score with incident type 2 diabetes mellitus: A nested case-control study.J Diabetes. 2024 Mar;16(3):e13512. doi: 10.1111/1753-0407.13512. Epub 2023 Dec 7. J Diabetes. 2024. PMID: 38062913 Free PMC article.
-
A systematic review and metaanalysis of observational studies on the effects of epigenetic factors on serum triglycerides.Arch Endocrinol Metab. 2022 May 13;66(3):407-419. doi: 10.20945/2359-3997000000472. Epub 2022 May 12. Arch Endocrinol Metab. 2022. PMID: 35551677 Free PMC article.
Cited by
-
Biological Functions and Clinical Significance of the ABCG1 Transporter.Biology (Basel). 2024 Dec 25;14(1):8. doi: 10.3390/biology14010008. Biology (Basel). 2024. PMID: 39857239 Free PMC article. Review.
-
Metabolic memory: mechanisms and diseases.Signal Transduct Target Ther. 2024 Feb 28;9(1):38. doi: 10.1038/s41392-024-01755-x. Signal Transduct Target Ther. 2024. PMID: 38413567 Free PMC article. Review.
-
DNA methylation and type 2 diabetes: a systematic review.Clin Epigenetics. 2024 May 16;16(1):67. doi: 10.1186/s13148-024-01670-6. Clin Epigenetics. 2024. PMID: 38755631 Free PMC article.
-
Metabolite profiles and DNA methylation in metabolic syndrome: a two-sample, bidirectional Mendelian randomization.Front Genet. 2023 Sep 15;14:1184661. doi: 10.3389/fgene.2023.1184661. eCollection 2023. Front Genet. 2023. PMID: 37779905 Free PMC article.
-
Epigenetics of methylation modifications in diabetic cardiomyopathy.Front Endocrinol (Lausanne). 2023 Mar 15;14:1119765. doi: 10.3389/fendo.2023.1119765. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37008904 Free PMC article. Review.
References
-
- Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14:88–98. - PubMed
-
- International Diabetes Federation. IDF Diabetes Atlas, 9th edn. https://diabetesatlas.org .
-
- Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444:840–6. - PubMed
-
- Rawshani A, Rawshani A, Gudbjörnsdottir S. Smoking and other risk factors in type 2 diabetes. N Engl J Med. 2018;379:2575. - PubMed
-
- Knott C, Bell S, Britton A. Alcohol consumption and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of more than 1.9 million individuals from 38 observational studies. Diabetes Care. 2015;38:1804–12. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical